Advanced 0 8 0 8 O
localized 9 18 9 18 O
disease 19 26 19 26 O
unlikely 27 35 27 35 O
to 36 38 36 38 O
be 39 41 39 41 O
cured 42 47 42 47 O
by 48 50 48 50 O
local 51 56 51 56 O
primary 57 64 57 64 O
intervention 65 77 65 77 O
with 78 82 78 82 O
either 83 89 83 89 O
surgery 90 97 90 97 B-treatment
or 98 100 98 100 O
radiation 101 110 101 110 B-treatment
with 111 115 111 115 O
curative 116 124 116 124 O
intent 125 131 125 131 O

Evidence 0 8 132 140 O
of 9 11 141 143 O
biochemical 12 23 144 155 O
( 24 25 156 157 O
PSA 25 28 157 160 O
) 28 29 160 161 O
or 30 32 162 164 O
clinical 33 41 165 173 O
relapse 42 49 174 181 O
following 50 59 182 191 O
local 60 65 192 197 O
primary 66 73 198 205 O
intervention 74 86 206 218 O
with 87 91 219 223 O
curative 92 100 224 232 O
intent 101 107 233 239 O
, 107 108 239 240 O
such 109 113 241 245 O
as 114 116 246 248 O
surgery 117 124 249 256 B-treatment
, 124 125 256 257 O
radiation 126 135 258 267 B-treatment
therapy 136 143 268 275 I-treatment
, 143 144 275 276 O
cryotherapy 145 156 277 288 B-treatment
, 156 157 288 289 O
or 158 160 290 292 O
high 161 165 293 297 O
- 165 166 297 298 O
frequency 166 175 298 307 O
ultrasound 176 186 308 318 O
and 187 190 319 322 O
not 191 194 323 326 O
a 195 196 327 328 O
candidate 197 206 329 338 O
for 207 210 339 342 O
salvage 211 218 343 350 B-treatment
treatment 219 228 351 360 I-treatment
by 229 231 361 363 I-treatment
surgery 232 239 364 371 I-treatment

Has 0 3 372 375 O
a 4 5 376 377 O
serum 6 11 378 383 B-clinical_variable
PSA 12 15 384 387 I-clinical_variable
concentration 16 29 388 401 I-clinical_variable
at 30 32 402 404 O
the 33 36 405 408 O
Screening 37 46 409 418 O
visit 47 52 419 424 O
of 53 55 425 427 O
> 56 57 428 429 O
2.0 58 61 430 433 B-lower_bound
ng 62 64 434 436 I-lower_bound
/ 64 65 436 437 I-lower_bound
mL 65 67 437 439 I-lower_bound
( 68 69 440 441 I-lower_bound
2.0 69 72 441 444 I-lower_bound
μg 73 75 445 447 I-lower_bound
/ 75 76 447 448 I-lower_bound
L 76 77 448 449 I-lower_bound
) 77 78 449 450 I-lower_bound
, 78 79 450 451 O
or 80 82 452 454 O
, 82 83 454 455 O
when 84 88 456 460 O
applicable 89 99 461 471 O
, 99 100 471 472 O
post 101 105 473 477 O
radical 106 113 478 485 B-treatment
prostatectomy 114 127 486 499 I-treatment
of 128 130 500 502 O
> 131 132 503 504 O
0.2 133 136 505 508 B-lower_bound
ng 137 139 509 511 I-lower_bound
/ 139 140 511 512 I-lower_bound
mL 140 142 512 514 I-lower_bound
( 143 144 515 516 I-lower_bound
0.2 144 147 516 519 I-lower_bound
μg 148 150 520 522 I-lower_bound
/ 150 151 522 523 I-lower_bound
L 151 152 523 524 I-lower_bound
) 152 153 524 525 I-lower_bound
or 154 156 526 528 O
post 157 161 529 533 O
radiotherapy 162 174 534 546 B-treatment
, 174 175 546 547 O
cryotherapy 176 187 548 559 B-treatment
, 187 188 559 560 O
or 189 191 561 563 O
high 192 196 564 568 B-treatment
frequency 197 206 569 578 I-treatment
ultrasound 207 217 579 589 I-treatment
> 218 219 590 591 O
2.0 220 223 592 595 O
ng 224 226 596 598 O
/ 226 227 598 599 O
mL 227 229 599 601 O
( 230 231 602 603 O
2.0 231 234 603 606 O
μg 235 237 607 609 O
/ 237 238 609 610 O
L 238 239 610 611 O
) 239 240 611 612 O
above 241 246 613 618 O
the 247 250 619 622 O
post 251 255 623 627 O
interventional 256 270 628 642 O
nadir 271 276 643 648 O

Has 0 3 649 652 O
a 4 5 653 654 O
serum 6 11 655 660 B-clinical_variable
testosterone 12 24 661 673 I-clinical_variable
at 25 27 674 676 O
the 28 31 677 680 O
Screening 32 41 681 690 O
visit 42 47 691 696 O
of 48 50 697 699 O
≥ 51 52 700 701 O
150 53 56 702 705 B-lower_bound
ng 57 59 706 708 I-lower_bound
/ 59 60 708 709 I-lower_bound
dL 60 62 709 711 I-lower_bound
( 63 64 712 713 I-lower_bound
5.2 64 67 713 716 I-lower_bound
nmol 68 72 717 721 I-lower_bound
/ 72 73 721 722 I-lower_bound
L 73 74 722 723 I-lower_bound
) 74 75 723 724 I-lower_bound

Has 0 3 725 728 O
an 4 6 729 731 O
Eastern 7 14 732 739 B-clinical_variable
Cooperative 15 26 740 751 I-clinical_variable
Oncology 27 35 752 760 I-clinical_variable
Group 36 41 761 766 I-clinical_variable
( 42 43 767 768 I-clinical_variable
ECOG 43 47 768 772 I-clinical_variable
) 47 48 772 773 I-clinical_variable
performance 49 60 774 785 I-clinical_variable
status 61 67 786 792 I-clinical_variable
of 68 70 793 795 O
0 71 72 796 797 B-lower_bound
or 73 75 798 800 O
1 76 77 801 802 B-upper_bound
at 78 80 803 805 O
initial 81 88 806 813 O
screening 89 98 814 823 O
and 99 102 824 827 O
at 103 105 828 830 O
baseline 106 114 831 839 O

History 0 7 840 847 O
of 8 10 848 850 O
surgical 11 19 851 859 B-treatment
castration 20 30 860 870 I-treatment

Is 0 2 871 873 O
a 3 4 874 875 O
candidate 5 14 876 885 O
for 15 18 886 889 O
, 18 19 889 890 O
in 20 22 891 893 O
the 23 26 894 897 O
opinion 27 34 898 905 O
of 35 37 906 908 O
the 38 41 909 912 O
investigator 42 54 913 925 O
, 54 55 925 926 O
at 56 58 927 929 O
least 59 64 930 935 O
1 65 66 936 937 B-lower_bound
year 67 71 938 942 I-lower_bound
of 72 74 943 945 O
continuous 75 85 946 956 O
androgen 86 94 957 965 B-treatment
deprivation 95 106 966 977 I-treatment
therapy 107 114 978 985 I-treatment
for 115 118 986 989 O
the 119 122 990 993 O
management 123 133 994 1004 O
of 134 136 1005 1007 O
androgen 137 145 1008 1016 O
- 145 146 1016 1017 O
sensitive 146 155 1017 1026 O
advanced 156 164 1027 1035 O
prostate 165 173 1036 1044 B-cancer
cancer 174 180 1045 1051 I-cancer
with 181 185 1052 1056 O
one 186 189 1057 1060 O
of 190 192 1061 1063 O
the 193 196 1064 1067 O
following 197 206 1068 1077 O
clinical 207 215 1078 1086 O
disease 216 223 1087 1094 O
state 224 229 1095 1100 O
presentations 230 243 1101 1114 O

Metastases 0 10 1115 1125 B-cancer
to 11 13 1126 1128 I-cancer
brain 14 19 1129 1134 I-cancer
per 20 23 1135 1138 O
prior 24 29 1139 1144 O
clinical 30 38 1145 1153 O
evaluation 39 49 1154 1164 O

Newly 0 5 1165 1170 O
diagnosed 6 15 1171 1180 O
androgen 16 24 1181 1189 O
- 24 25 1189 1190 O
sensitive 25 34 1190 1199 O
metastatic 35 45 1200 1210 B-cancer
disease 46 53 1211 1218 I-cancer

Previously 0 10 1219 1229 O
received 11 19 1230 1238 O
GnRH 20 24 1239 1243 O
analog 25 31 1244 1250 O
or 32 34 1251 1253 O
other 35 40 1254 1259 O
form 41 45 1260 1264 O
of 46 48 1265 1267 O
androgen 49 57 1268 1276 B-treatment
deprivation 58 69 1277 1288 I-treatment
therapy 70 77 1289 1296 I-treatment
( 78 79 1297 1298 O
estrogen 79 87 1298 1306 O
or 88 90 1307 1309 O
antiandrogen 91 103 1310 1322 O
) 103 104 1322 1323 O
for 105 108 1324 1327 O
> 109 110 1328 1329 O
18 111 113 1330 1332 B-lower_bound
months 114 120 1333 1339 I-lower_bound
total 121 126 1340 1345 O
duration 127 135 1346 1354 O

Scheduled 0 9 1355 1364 O
for 10 13 1365 1368 O
major 14 19 1369 1374 B-treatment
surgery 20 27 1375 1382 I-treatment
after 28 33 1383 1388 O
baseline 34 42 1389 1397 O

